Search Results

Melanotan II 10mg 10mg  | Purity Not Available

Adooq Bioscience

Melanotan II is a high affinity melanocortin receptor agonist (Ki values are 0.67, 6.6, 34 and 46 nM for MC1, MC4, MC3 and MC5 receptors respectively).

More Information Supplier Page

Endoxifen 50mg 50mg  | Purity Not Available

Adooq Bioscience

Endoxifen is a secondary metabolite of tamoxifen. It is a primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer.

More Information Supplier Page

Endoxifen 25mg 25mg  | Purity Not Available

Adooq Bioscience

Endoxifen is a secondary metabolite of tamoxifen. It is a primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer.

More Information Supplier Page

Endoxifen 10mg 10mg  | Purity Not Available

Adooq Bioscience

Endoxifen is a secondary metabolite of tamoxifen. It is a primary metabolite responsible for the effectiveness of tamoxifen in ER-positive breast cancer.

More Information Supplier Page

MBX-2982 5mg 5mg  | Purity Not Available

Adooq Bioscience

MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.

More Information Supplier Page

MBX-2982 25mg 25mg  | Purity Not Available

Adooq Bioscience

MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.

More Information Supplier Page

MBX-2982 10mg 10mg  | Purity Not Available

Adooq Bioscience

MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.

More Information Supplier Page

Combretastatin A4 50mg 50mg  | Purity Not Available

Adooq Bioscience

Combretastatin A4 is an antitumor, antiangiogenic and antimetastatic agent, in vitro and in vivo. Inhibits tubulin polymerization.

More Information Supplier Page